Literature DB >> 629857

Chemical modifications of the protein of carcinoembryonic antigen: associated changes in immunological activity and conformation.

J H Westwood, P Thomas, R G Edwards, P M Scopes, M W Barrett.   

Abstract

Chemical substitution of the exposed residues of tryptophan, tyrosine, histidine and arginine in carcinoembryonic antigen (CEA), using appropriately selective reagents, caused no significant change in the capacity of the antigen to bind to anti-CEA serum. However, treatments of CEA with 2-hydroxy-5-nitrobenzyl bromide and tetranitromethane, both in the presence of guanidine HCl, caused a large reduction in binding capacity. Measurement of the circular dichroism spectra of all of the products showed that retention of conformation of the molecular correlated well with retained antigenic activity, whereas the large losses in capacity to bind to anti-CEA sera were accompanied by a probably the result of gross conformational changes. The tyrosine residues of CEA may be classified into three categories: (i) 3 freely reacting residues, (ii) 7 or 8 moderately buried residues and (iii) 15 unreactive residues.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629857      PMCID: PMC2009592          DOI: 10.1038/bjc.1978.26

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  FUNCTIONAL TYROSYL RESIDUES IN THE ACTIVE CENTER OF BOVINE PANCREATIC CARBOXYPEPTIDASE A.

Authors:  R T SIMPSON; J F RIORDAN; B L VALLEE
Journal:  Biochemistry       Date:  1963 May-Jun       Impact factor: 3.162

3.  The role of histidine residues in glutamate dehydrogenase.

Authors:  N Tudball; R Bailey-Wood; P Thomas
Journal:  Biochem J       Date:  1972-09       Impact factor: 3.857

4.  Studies on the structure of the carcinoembryonic antigen. I. some deductions on the basis of chemical degradations.

Authors:  J H Westwood; E M Bessell; M A Bukhari; P Thomas; J M Walker
Journal:  Immunochemistry       Date:  1974-12

Review 5.  The determination of carbohydrate in biological materials by gas-liquid chromatography.

Authors:  J R Clamp; T Bhatti; R E Chambers
Journal:  Methods Biochem Anal       Date:  1971

6.  Effects of chemical modification of the protein on the antigenic activity of carcinoembryonic antigen.

Authors:  P Thomas; R G Edwards; J H Westwood
Journal:  Biochem Soc Trans       Date:  1976       Impact factor: 5.407

7.  Essential arginyl residues in reverse transcriptase.

Authors:  C L Borders; J F Riordan; D S Auld
Journal:  Biochem Biophys Res Commun       Date:  1975-09-16       Impact factor: 3.575

8.  Conformational transitions associated with the release of the buried tryptophan residues of alpha-1-acid glycoprotein.

Authors:  K Yamagami; K Schmid
Journal:  J Biol Chem       Date:  1967-09-25       Impact factor: 5.157

9.  Physicochemical studies of the carcinoembryonic antigens of the human digestive system.

Authors:  J Krupey; P Gold; S O Freedman
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

10.  Studies on the structure and immunological activity of carcinoembryonic antigen - the role of disulphide bonds.

Authors:  J H Westwood; P Thomas
Journal:  Br J Cancer       Date:  1975-12       Impact factor: 7.640

View more
  3 in total

Review 1.  Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma.

Authors:  J M Jessup; P Thomas
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

2.  A new Kupffer cell receptor mediating plasma clearance of carcinoembryonic antigen by the rat.

Authors:  C A Toth; P Thomas; S A Broitman; N Zamcheck
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

3.  Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model.

Authors:  J B Quayle
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.